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ABSTRACT 
Oral glucose tolerance test (OGTT) is usually insufficient to accurately predict the risk for type 2 diabetes mellitus 
(T2DM), it is therefore necessary to identify an additional biomarker that would most likely improve the accuracy 
of OGTT. The current OGTT was performed in 53 volunteers after ingestion of 75 g glucose in 250 ml water to 
each volunteer. Similarly the sphingoid base profile of these volunteers was explored using liquid-chromatography 
linked with mass spectrometer (LC-MS) and correlated with the different time-points glucose values of OGTT as 
well as with total area under the curve (tAUC), incremental area under the curve (iAUC), and positive incremental 
area under the curve (pAUC). The findings showed that 1-deoxysphinganine (1-deoxySA) was significantly posi-
tively correlated with the 1-hour, 2-hour, and 3-hour plasma glucose level as well as with total, incremental, and 
positive incremental AUC while 1-deoxysphingosine (1-deoxySO) was correlated only with 1-hour, 2-hour glu-
cose levels and tAUC of OGTT. The C18SAdiene was negatively correlated with all-time points glucose values 
and AUCs followed by negative correlation of C18SO, C16SO and C17SO with 2-hour glucose and tAUC of 
OGTT. The ratios of 1-deoxySA and 1-deoxySO with respect to C18SAdiene have shown significant correlation 
with 2-hour and AUCs. These ratios were higher in subjects with gestational diabetes in comparison with normal 
subjects. These findings underlined that 1-deoxysphingolipids (1-deoxySLs) and their ratios with C18SAdiene 
could be significantly correlated with the glucose load of OGTT and might be used as predictive biomarkers along 
with OGTT for the risk assessment of diabetes.  
 
Keywords: gestational diabetes, oral glucose tolerance test, basal glucose, area under the curve, correlation, sphin-
goid-bases 
 
 
 
INTRODUCTION 
Gestational diabetes mellitus (GDM) is 
defined as glucose intolerance of variable se-
verity with onset or first recognition during 
pregnancy (Schmidt et al., 2001). GDM or 
impaired glucose tolerance (IGT) that is first 
diagnosed during pregnancy affects ~14 % of 
pregnancies and is also a risk factor for type 2 
diabetes in the mother. However screening of 
GDM may be applied for the identification of 
mothers at higher risk for type 2 diabetes and 
intervention in subjects with IGT has been re-
vealed to delay the onset of type 2 diabetes 
(Kim et al., 2002). The currently existing 
methodologies for the diagnosis of prediabe-
tes such as glycated hemoglobin (HbA1c) and 
fasting glucose (FG) are inadequate for the 
EXCLI Journal 2017;16:497-509 – ISSN 1611-2156 
Received: January 24, 2017, accepted: March 28, 2017, published: April 18, 2017 
 
 
498 
detection of individuals at risk as HbA1c may 
be altered in anemia or renal failure or remain 
normal in mild dysglycemia (Buysschaert et 
al., 2015). The OGTT is a useful tool to pro-
voke a metabolic challenge not only for diag-
nostic purposes but also for scientific pur-
poses to monitor the pharmacokinetic of glu-
cose (Abdul-Ghani et al., 2009). Since the 2-
hour OGTT is considered as gold standard 
method for the diagnosis of type 2 diabetes as 
it is most commonly used in clinical practice 
and research for the identification of people 
with normal or IGT as well as patients with 
type 2 diabetes (Andrikopoulos et al., 2008). 
In OGTT blood glucose is usually measured 
before (after an overnight 10-16 hour fasting) 
and at 2 or 3 hours after ingestion of 75 g glu-
cose dissolved in 200-250 ml of water. The 2-
hours glucose values are then compared with 
the standard WHO values to know about nor-
mal, impaired glucose and diabetes 
(Kjøllesdal et al., 2014). According to WHO 
recommendations diabetes can be diagnosed 
either on elevated fasting blood glucose level 
(≥ 7 mM) or on 2-hour plasma glucose level 
(≥ 11 mM) of OGTT after ingestion of 75 g 
glucose solution preceded by an overnight 
fasting (WHO, 2006). The WHO criteria 
based on blood glucose level measured at 2-
hour of OGTT is glucose value ≥ 7.8 mmol/l 
(140 mg/dl) but < 11.1 mmol/l (200 mg/dl) 
considered as IGT while values ≥ 11.1 mmol/l 
(200 mg/dl) as indicatives of diabetes (Zhou 
et al., 2006). As OGTT gives no idea about 
the total raise in blood glucose level 
(Kjøllesdal et al., 2014), the area under the 
curve (AUC) is usually applied to know about 
the total raise in blood glucose during an 
OGTT. For assessment of total blood glucose 
response vs time during OGTT the total, in-
cremental and positive incremental AUC 
have been applied in several studies with mer-
its and demerits (Wolever and Jenkins, 1986; 
Wolever et al., 1991; Allison et al., 1995; 
Kjøllesdal et al., 2014). The shortcoming of 
the OGTT is the limitation of evaluation only 
one or few metabolic factors simultaneously. 
Moreover the conventional risk factors like 
impaired fasting glucose (IFG) as well as im-
paired glucose tolerance (IGT) usually fail to 
predict 50 % of the patients prone to develop 
T2DM (Othman et al., 2015a). However the 
application of another metabolic biomarker 
along with glucose will not only enhance the 
understanding but also increase the precision 
and accuracy of diagnosis diabetes as well as 
other metabolic disorder (Andrikopoulos et 
al., 2008). Metabolomics’ approaches have 
been applied for the identification of novel bi-
omarkers as these can simultaneously quan-
tify metabolites that are products of different 
metabolic pathways. The identification of 
such biomarkers, the concentrations of which 
are altered in diabetes and prediabetes, may 
be helpful in explaining pathways that are in-
volved in diabetes. These biomarkers may be 
applied for the detection of earlier and more 
reliable dysfunction of glucose metabolism 
than other existing clinical markers of diabe-
tes (Buysschaert et al., 2015). In recent years 
several metabolites such as amino acids, 
phospholipids, and sphingolipids are becom-
ing candidates of biomarkers for the predic-
tion of future diabetes (Wang et al., 2011; 
Wang‐Sattler et al., 2012; Floegel et al., 2013; 
Othman et al., 2015a).  
Sphingoid bases are the shared structural 
element of all sphingolipids and are typically 
comprised of backbones 2-amino, 1, 3-diols 
synthesized from serine and palmitoyl-coen-
zyme A (palmitoyl-CoA) by the enzyme ser-
ine palmitoyltransferase (SPT). However, 
SPT can also metabolize other acyl-CoAs be-
sides palmitoyl-CoA to produce atypical 
sphingolipids having atypical chain length in 
the range of 12 to 26 carbons. In certain con-
ditions many organisms including mammals 
can also utilize L-alanine and glycine instead 
of L-serine to produce 1-deoxy sphingolipids 
(1-deoxySLs) that are made of 1-deoxysphin-
goid bases (DSBs) (Othman et al., 2015a). A 
low level of 1-deoxySA and 1-deoxySO are 
found in plasma of healthy individuals under 
normal physiological conditions (Wei et al., 
2014), however in pathophysiological condi-
tions these are produced in higher amount 
(Zuellig et al., 2014). Elevated 1-deoxySLs 
levels have been found in T2DM (Dohrn et 
al., 2015), metabolic syndrome (MetS) (Wei 
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et al., 2014), impaired fasting glucose (IFG) 
(Wei et al., 2014), non-alcoholic steatohepa-
titis (Gorden et al., 2015), and defects in ser-
ine biosynthesis (Esaki et al., 2015), and can 
be predicted for other conditions where meta-
bolic changes or diet alter the amounts (Mer-
rill and Carman, 2015). It is therefore as-
sumed that 1-deoxySLs can be used as predic-
tive biomarkers for the diagnosis of these dis-
eases. This study is designed to link OGTT to 
various sphingolipids metabolomics to ex-
plore novel metabolic biomarkers and path-
ways which are affected by the glucose me-
tabolism, thereby opening new perceptions to 
study the physiological behavior of the body 
on glucose metabolism. The correlation stud-
ies of these sphingoid bases with fasting, 1-
hour, 2-hour, and 3-hour glucose levels and 
area under the curve (AUC) were carried out 
in order to find out the relationship of these 
sphingolipids with OGTT.  
The aim of this study is to explore the cor-
relation of sphingoid bases with different glu-
cose levels of OGTT and tAUC, iAUC, and 
pAUC in order to show their relationship with 
glucose load and discover new metabolic bi-
omarkers and pathways that are influenced by 
glucose metabolism, thereby opening new 
perspectives in the study of the physiological 
reaction of the body on glucose ingestion. 
Moreover to investigate whether the 1-deox-
ysphingoid bases can be used as potential bi-
omarkers for the diagnosis of GDM and pre-
diction of risk for T2DM during OGTT in or-
der to improve further the accuracy and preci-
sion of OGTT.  
 
MATERIALS AND METHODS 
Subjects 
The study was conducted at Department 
of Clinical Chemistry, University Hospital 
Zurich. The study was approved by the ethical 
committee of the institute. Total fifty nine 
(N=59) volunteers participated in this study 
after their complete medical history, screen-
ing tests and informed written consent in ac-
cordance with the guidelines of the hospital 
for human experimentation and Helsinki Dec-
laration.  
 Oral Glucose Tolerance Test 
The subjects reported to the laboratory in 
the morning after an overnight fasting. All 
subjects were abstained from food or any 
other drink except water for 12-16 hours. The 
fasting blood samples were taken after insert-
ing a catheter into the prominent vein of fore-
arm. A 75 g standard glucose solution was 
given to the volunteers at 0 time-points. 
Plasma samples were collected at 1-hour, 2-
hour, and 3-hour time intervals from all the 
volunteers. These plasma samples were then 
analyzed for glucose using standard biochem-
ical protocols. After the data collection the to-
tal, incremental, and positive incremental 
AUC were measured using the trapezoidal 
method.  
 
 Sphingolipid analysis 
The different sphingoid bases such as 
C16-sphingosine (C16SO), C16-sphinganine 
(C16SA), C17-sphingosine (C17SO), C18-
sphingosine (C18SO), C18-sphinganine 
(C18SA), C18SA-diene, C19-sphingosine 
(C19SO), and the 1-deoxy-sphingoid bases 
i.e., 1-deoxy-sphingosine (1-deoxySO) and 1-
deoxy-sphinganine (1-deoxySA) were ana-
lyzed by liquid-chromatography mass spec-
trometry (LC-MS) in plasma samples of these 
volunteers. The sphingoid base profile was 
analyzed by the method reported by Othman 
et al. (2015a). The sphingoid-bases such as 
C16SO, C16SA, C17SO, C18SO, C18SA, 
C18SA-diene, C19SO, and DSBs including 
1-deoxySO and 1-deoxSA were separated on 
a C18 column (120 ºA, 5 mm, 125 × 2 mm; 
Uptispere; Interchim, Montlucon, France) us-
ing TSQ Quantum Ultra Mass Spectrometer 
(Thermo, Reinach, Basel-Landschaft, Swit-
zerland) after extraction and hydrolysis as re-
ported earlier (Othman et al., 2012, 2015b). 
Isotope-labelled d7-sphingosine (D7SO) and 
d7-sphinganine (D7SA) (200 pmol; Avanti 
Polar Lipids, Alabaster, AL) were used as in-
ternal standard. The plasma values of these 
sphingoid bases were quantified. 
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Statistical analysis  
Data are represented as mean ± SEM. Sta-
tistical correlation studies were carried out us-
ing SPSS Statistics 22 (IBM, Zurich, Switzer-
land) and GraphPad Prism 5 (GraphPad Soft-
ware, Inc., San Diego, CA). Pearson’s corre-
lation coefficient was calculated for the rela-
tionship between tAUC, iAUC, and pAUC 
and glucose values measured at 0, 1-hour, 2-
hour, and 3-hour time interval during OGTT. 
The total glucose response vs time was eval-
uated by area under the curve (AUC). For 
measuring the total glucose response vs time 
during an OGTT we applied the trapezoidal 
rule (Purves, 1992) to calculate total, incre-
mental, and positive incremental AUC. The 
tAUC depends on basal glucose value while 
the iAUC and pAUC are not related to basal 
glucose value. Since in incremental AUC the 
baseline values are subtracted from the subse-
quent values therefore a negative value will 
be obtained if any of the post baseline values 
are lower than the baseline value which con-
troverts the concept of area in the physical 
sense (Allison et al., 1995). Similarly during 
calculating the positive incremental AUC 
only the values above the baseline values are 
considered and those below the baseline are 
ignored (Wolever and Jenkins, 1986; Wolever 
et al., 1991). This also does not give the true 
picture of the data as it throws away much of 
the variance in any reading below the base-
line. So the total AUC represents the actual 
determination of total area under the curve 
and also minimizes the concerns with the 
other methods. Since the tAUC is independ-
ent of the ever-changing baseline glucose or 
insulin level therefore it might be the pre-
ferred method for the evaluation of a response 
during OGTT. The Pearson’s correlation co-
efficients were calculated for the relationship 
between sphingoid bases and glucose levels 
measured at 0, 1-hour, 2-hour, and 3-hour 
time interval during OGTT as well as for the 
relationship between sphingoid bases and to-
tal, incremental, and positive incremental 
AUC. Similarly the ratios of 1-deoxySA and 
1-deoxySO with respect to C18SAdiene were 
correlated with 2-h glucose values and tAUC 
of OGTT.  The level of significance was pre-
set at 5 % (P ≤ 0.05).  
 
RESULTS 
The descriptive statistics of glucose val-
ues measured at random, 0, 1, 2, and 3-hour 
time-points during an OGTT as well as age 
and plasma sphingoid bases of the under 
study subjects are given in Table 1. The val-
ues have been presented as minimum, maxi-
mum, and mean with their respective standard 
deviation. The mean age of the participants is 
33.50 years. The mean ± SD values for fast-
ing, 1-hour, 2-hour, and 3-hour glucose dur-
ing OGTT are 3.981 ± 1.70, 8.043 ± 1.945, 
6.430 ± 1.832, and 2.817 ± 2.194 mMol/L, re-
spectively. The data are showing greater var-
iation in the glucose values at 1, 2, and 3-hour 
of OGTT. The values of 1-deoxySA and 1-de-
oxySO are 0.199 ± 0.119 and 0.140 ± 0.103 
mΜ/L, respectively. The total, incremental, 
and positive incremental AUC were calcu-
lated using the trapezoidal rule for the evalu-
ation of the total blood glucose response vs 
time during OGTT. The respective mean ± 
SD values of tAUC, iAUC, and pAUC are 
18.234 ± 4.146, 7.919 ± 4.767, and 8.769 ± 
4.277 mM.h/L as given in Table 1.  
Based on the WHO guidelines for 2-hour 
post load blood glucose values the individuals 
were screened for IGT and diabetes. It has 
been found that out of 53 individuals only one 
has been diagnosed with diabetes as the 2-
hour blood glucose value was 11.9 mmol/L (≥ 
11.1 mmol/L), 11 (20.75 %) were diagnosed 
with IGT as their 2-hour blood glucose values 
were ≥ 7.8 mmol/L, while the remaining 41 
(77.36 %) were found normal. The screening 
results of our study based on WHO 2-hours 
blood glucose values are graphically repre-
sented in Figure 1. 
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Table 1: Descriptive statistics of the glucose level measured at 0, 1, 2, and 3-hour and different sphin-
goid-bases of participants during Oral Glucose Tolerance Test (OGTT) 
Parameters No Minimum Maximum Mean Std.  
Deviation 
C16SO 53 4.246 23.764 10.769 3.908 
C16SA 53 0.075 0.743 0.361 0.157 
C17SO 53 3.019 12.002 5.629 1.844 
C18SO 59 38.478 108.912 75.925 15.982 
C18SA 53 0.855 6.249 3.027 1.1129 
C18SAdiene 53 9.852 32.528 19.531 5.449 
C19SO 53 0.461 3.242 1.359 0.551 
1-deoxySO 53 0.018 0.715 0.140 0.103 
1-deoxySA 53 0.029 0.742 0.199 0.119 
1h Glucose 53 4.300 13.800 8.043 1.946 
2h Glucose 53 2.900 11.900 6.430 1.194 
3h Glucose 41 2.500 7.400 2.817 2.418 
Age (Years) 53 22.00 47.00 33.509 5.079 
Fasting Glucose 53 3.600 7.800 3.981 1.701 
tAUC 53 12.250 30.250 18.234 4.146 
iAUC 53 0.100 21.500 7.919 4.767 
pAUC 53 2.150 21.500 8.769 4.277 
 
 
 
 
Figure 1: Distribution of subjects as normal (41), 
IGT (11) and diabetic (1) on WHO criteria based 
on blood glucose level measured at 2-hour during 
an Oral Glucose Tolerance Test (OGTT) (glucose 
value ≥ 7.8 mmol/l (140 mg/dl) but < 11.1 mmol/l 
(200 mg/dl) considered as IGT while values ≥ 11.1 
mmol/l (200 mg/dl) as indicatives of diabetes) 
(N=53). 
 
The Pearson’s correlations of various 
sphingoid bases with age, 0 time (fasting), 1-
hour, 2-hour, and 3-hour glucose levels have 
been carried out to find out the relationship of 
the sphingoid bases with the different time 
points glucose level of OGTT as shown in Ta-
ble 2. 1-deoxySA was highly correlated with 
2-hour glucose level (0.536), followed by 1-
hour (0.418) glucose values of OGTT. Simi-
larly 1-deoxySO was best correlated with 2-
hour glucose values (0.332), followed by 1-
hour glucose values (0.309) of OGTT. The 
correlations of both of these sphingoid bases 
with fasting and 3-hour glucose values of 
OGTT were non-significant. All the other 
sphingoid bases’ correlations were either neg-
ative or non-significant. The best negative 
correlation was shown by C18SAdine with 2-
hour glucose values (‒0.692), followed by 1-
hour glucose values of OGTT. Similarly the 
other sphingoid bases that were highly nega-
tively correlated with 2-hour glucose values 
of OGTT include C18SO (‒0.581), C16SO  
(‒0.548), and C17SO (‒0.404), respectively. 
The correlations of C16SA, C18SA, and 
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C19SO were non-significant with the glucose 
values of OGTT. The Pearson’s correlation of 
the sphingoid bases with tAUC, iAUC, and 
pAUC was also calculated. The best correla-
tion has been shown for 1-deoxySA with 
tAUC (0.476), followed by its correlation 
with pAUC (0.348), and iAUC (0.329), re-
spectively. The correlation of 1-deoxySO 
with tAUC was significant (0.318), while 
with pAUC, and iAUC its correlations were 
non-significant.  The C18SAdiene was best 
negatively correlated with pAUC (‒0.560), 
followed by iAUC (‒0.530), and tAUC  
(‒0.470), respectively. Similarly C18SO, 
C17SO, and C16SO were highly negatively 
correlated with tAUC, iAUC, and pAUC, 
while correlations of C16SA, C18SA, and 
C19SO with tAUC, iAUC, and pAUC were 
non-significant as shown in Table 2. The scat-
ter plots of 1-deoxySA, 1-deoxySO and 
C18SAdiene concentration vs 2-hour glucose 
levels and tAUC of OGTT are presented in 
Figure 2.
 
Figure 2: Scatterplots for the relationship between doxSA, doxSO, C18SAdiene and 2-hour blood glu-
cose values and total Area Under the Curve (tAUC), during an Oral Glucose Tolerance Test (OGTT). 
Note: Pearson’s correlations’ coefficients for doxSA, doxSO, C18SAdiene and 2-hour glucose level of 
OGTT are (r=0.536; r=0.332 and r= ‒ 0.692) and for total area under the curve (tAUC) of OGTT are (r= 
0.476; r= 0.318; and r= ‒0.470) (N=53; p ≤ 0.001).
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Table 2: Pearson’s Correlations showing the relationship of different sphingoid bases with glucose level of 0, 1, 2, and 3-hour and Total Area Under the Curve (tAUC), 
Incremental Area Under the Curve (iAUC), and Positive Incremental Area Under the Curve (pAUC) during an Oral Glucose Tolerance Test (OGTT) 
 
Para- 
meters 
Correlations C16SO C16SA C17SO C18SO C18SA C18SAdiene C19SO 1-deoxySO 1-deoxySA DoxSA/SAdiene DoxSO/SAdiene 
Fasting 
Glucose 
Pearson 
Correlation 
0.162 0.068 0.157 -0.056 -0.042 0.132 -0.015 0.173 0.133 0.071 0.109 
 Sig.  
(2-tailed) 
0.247 0.626 0.260 0.689 0.767 0.345 0.915 0.216 0.343 0.611 0.435 
1h 
Glucose 
Pearson 
Correlation 
-0.339* 0.015 -0.250 -0.299* 0.226 -0.446** 0.093 0.309* 0.418** 0.510** 0.410** 
 Sig.  
(2-tailed) 
0.013 0.917 0.071 0.029 0.103 0.001 0.506 0.024 0.002 0.000 0.002 
2h 
Glucose 
Pearson 
Correlation 
-0.548** -0.117 -0.404** -0.581** 0.128 -0.692** -0.091 0.332* 0.536** 0.700** 0.518** 
 Sig.  
(2-tailed) 
0.001 0.406 0.003 0.001 0.360 0.000 0.515 0.015 0.001 0.000 0.000 
3h 
Glucose 
Pearson 
Correlation 
-0.030 -0.091 0.003 -0.145 -0.056 0.053 -0.039 0.153 0.203 0.158 0.137 
 Sig.  
(2-tailed) 
0.830 0.518 0.982 0.299 0.690 0.704 0.782 0.275 0.144 0.259 0.328 
Age Pearson 
Correlation 
0.060 0.016 0.249 0.166 -0.024 0.038 0.198 0.017 -0.063 -0.013 0.038 
 Sig.  
(2-tailed) 
0.670 0.911 0.072 0.234 0.867 0.787 0.156 0.903 0.655 0.926 0.787 
tAUC Pearson 
Correlation 
-0.368** -0.031 -0.270 -0.443** 0.203 -0.470** 0.009 0.318* 0.476** 0.569** 0.432** 
 Sig.  
(2-tailed) 
0.007 0.824 0.050 0.001 0.144 0.001 0.948 0.021 0.001 0.000 0.001 
iAUC Pearson 
Correlation 
-0.471** -0.109 -0.369** -0.339* 0.159 -0.530** 0.005 0.166 0.329* 0.462** 0.320* 
 Sig.  
(2-tailed) 
0.001 0.439 0.007 0.013 0.257 0.000 0.973 0.236 0.016 0.001 0.020 
pAUC Pearson 
Correlation 
-0.463** -0.085 -0.379** -0.352** 0.183 -0.560** 0.001 0.178 0.348* 0.489** 0.336* 
  0.001 0.547 0.005 0.010 0.190 0.000 0.996 0.202 0.011 0.001 0.014 
 
*   Correlation is significant at the 0.05 level (2-tailed); ** Correlation is significant at the 0.01 level (2-tailed)
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The ratios of 1-deoxySA, and 1-deox-
ySO concentration with respect to C18SA-
diene concentration during OGTT were 
measured. The Pearson’s correlation of 
these ratios with glucose levels and AUCs 
of OGTT are shown in Table 2. These ratios 
were highly correlated with 2-hour blood 
glucose levels and tAUC of OGTT. The 1-
deoxySA/C18SAdiene ratio was highly cor-
related with 2-hour blood glucose load 
(r=0.700) and tAUC (r=0.569) of OGTT. 
Similarly the 1-deoxySO/C18SAdiene ratio 
was also significantly correlated with 2-
hour plasma glucose level (r= 0.518) and 
tAUC (r=0.432) of OGTT. The scatter plots 
of 1-deoxySA/C18SAdiene and 1-deox-
ySO/C18SAdiene vs 2-hour blood glucose 
and tAUC of OGTT are presented in Figure 
3.  
 
Figure 3: Scatterplots for the relationship between ratios of (1-deoxySA/C18SAdiene) and (1-deoxySO/ 
C18SAdiene) with 2-hour blood glucose values and total Area under the Curve (tAUC) of an Oral Glu-
cose Tolerance Test (OGTT) (N=53).
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The ratios of 1-deoxySA and 1-deoxySO 
with respect to C18SAdiene were compared 
between subjects with gestational diabetes 
and subjects having normal 2-hour glucose 
values of OGTT. The Pearson’s correlations 
of 1-deoxySA/C18SAdiene and 1-deox-
ySO/C18SAdiene ratios with 2-h glucose 
values of OGTT in normal and subjects with 
IGT were compared. The correlations of 1-
deoxySA/C18SAdiene and 1-deoxySO/ 
C18SAdiene vs 2-h glucose values of 
OGTT are r=0.859, and r=0.875 in subjects 
with IGT and r=0.44, and r=0.182 in normal 
subjects, respectively, as shown in Figure 4.  
 
Figure 4: Comparison of the ratios of doxSA/C18SAdiene and doxSO/C18SAdiene against 2-h glucose 
values of OGTT in normal (N=41) and subjects with gestational diabetes (N=12). 
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DISCUSSION 
Oral glucose tolerance test (OGTT) is the 
screening test that is applied to measure 
plasma glucose level of an individual after in-
gestion of 75 grams of glucose solution. It is 
commonly used to define glucose tolerance 
for practical purposes and confirms the diag-
nosis of gestational diabetes, type 2 diabetes, 
and other metabolic diseases (Dedík et al., 
2003). In clinical practice simple summary 
measures like fasting, one-hour (1-h), two-
hour (2-h) values, and area under the curve 
(AUC) are commonly applied to get infor-
mation about the glucose tolerance (Yogev et 
al., 2004; Siegmund et al., 2008). In compari-
son with fasting, or 2-h glucose value AUC is 
the better measure to capture the essential 
temporal information of OGTT glucose 
curves. The major shortcoming of OGTT is 
the limitation of measuring only glucose as 
metabolic factor. The correlation of OGTT 
with another metabolic marker other than glu-
cose at the same time will not only increase 
its understanding but will also increase its ac-
curacy and precision in the diagnosis of met-
abolic disorders.  The aim of our study is to 
identify the other metabolic biomarker that 
shows relationship with glucose during 
OGTT which improves the diagnostic utility 
of the OGTT and enhances our understanding 
of metabolism in health and disease. In this 
study glucose response vs time is not only 
evaluated by one-hour (1-h), two-hour (2-h), 
three-hour (3-h) values of OGTT, but also the 
total glucose response vs time was evaluated 
by area under the curve (AUC). The sphin-
goid base profile was correlated with blood 
glucose levels and AUCs of OGTT. The ratios 
of 1-deoxySA/C18SAdiene and 1-deoxySO/ 
C18SAdiene were also correlated with blood 
glucose levels and AUCs of OGTT. 
Among the studied sphingoid bases the 1-
deoxy-sphingoid-bases (1-deoxySA and 1-
deoxySO) showed significant positive corre-
lation with the different time points glucose 
level and tAUC, pAUC, and iAUC of OGTT 
while the C18SAdiene, C18SO, C17SO, and 
C16SO sphingoid bases showed significantly 
negative correlation. The correlations of other 
sphingoid bases were non-significant. The 1-
deoxySA has shown strong correlation with 
glucose values of 1-hour, 2-hour, and 3-hour 
of OGTT as well with tAUC, pAUC, and 
iAUC; however 1-deoxySO was significantly 
correlated only with 1-hour, 2-hour glucose 
values and tAUC of OGTT. The 2-hour glu-
cose was strongly correlated with 1-doxySA 
and 1-doxySO as compared to 1-hour and 3-
hour correlations. Similarly the tAUC was 
highly correlated with 1-deoxySA and 1-
doxySO in comparison with pAUC, and 
iAUC correlations. It has been observed that 
the serine-based sphingoid bases were nega-
tively correlated while alanine-based sphin-
goid bases were positively correlated with 
glucose load of OGTT. The ratios of 1-deox-
ySA/C18SAdiene and 1-deoxySO/C18SAdi-
ene with respect to blood glucose levels and 
AUCs of OGTT have shown significant cor-
relation indicating that serine based sphingoid 
bases decreased while alanine based sphin-
goid bases increased with glucose load of 
OGTT. The C16 and C18-sphingoid bases are 
functionally linked to serine whereas 1-deox-
ySLs are linked to alanine metabolism. As the 
alanine to serine ratio might increase with the 
glucose value of OGTT therefore the ratios of 
1-deoxySA/C18SAdiene and 1-deoxySO/ 
C18SAdiene with respect to blood glucose 
levels and AUCs of OGTT were highly corre-
lated. The ratios of 1-deoxySA and 1-deoxy-
SO with respect to C18SAdiene are higher in 
subjects with gestational diabetes in compari-
son with subjects having normal 2-hour glu-
cose values of OGTT. This shows that alanine 
to serine ratio was increased in patients with 
gestational diabetes as compared to normal 
subjects. The possible mechanism might be 
the increased availability of intracellular ala-
nine in the hyperglycemic conditions during 
OGTT. Sphingolipid metabolism represents a 
metabolic cross point which interconnects li-
pid (acyl-CoA) and amino acid (serine, ala-
nine, and glycine) metabolism. The cellular 
production of serine and alanine is function-
ally connected to carbohydrate metabolism 
due to formation of their precursors 3-phos-
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phoglycerate and pyruvate and thereby indi-
rectly linked to carbohydrate metabolism. 
That is why the observed changes show a 
functional interaction between sphingolipids 
and glucose metabolism thereby increase the 
production of 1-deoxySLs in diabetes (Bertea 
et al., 2010). In previous studies hyperglyce-
mia was linked to changes of some sphingoid 
bases especially to the increased production 
of DSBs (Bertea et al., 2010; Othman et al., 
2012). Hyperglycemic conditions are associ-
ated with elevated hepatic glucose levels and 
an increased glycolytic flux hence increases 
the formation of pyruvate and its conversion 
to either lactate or alanine. Elevated glucose 
levels could increase hepatic alanine and 
thereby deoxy-sphingolipids production. 
These results indicate a functional interaction 
between sphingolipid and glucose metabo-
lism (Othman et al., 2012). 
This study is a valuable addition to other 
reported metabolomics studies on OGTT 
(Shaham et al., 2008; Zhao et al., 2009; 
Spégel et al., 2010). In previous studies it has 
been reported that 1-deoxySLs are elevated in 
MetS (Othman et al., 2012), T2DM (Bertea et 
al., 2010), and in patients with IFG (Othman 
et al., 2015b) and their plasma levels are sig-
nificantly and independently associated with 
a higher risk of developing (Othman et al., 
2015b). In this study the different time points 
glucose level as well AUCs of OGTT were 
correlated with the sphingoid bases of the 
plasma for the first time to investigate the as-
sociation of these sphingoid bases with 
OGTT. Similarly the ratios of 1-deox-
ySA/C18SAdiene and 1-deoxySO/C18SAdi-
ene were also correlated with blood glucose 
level and AUCs of OGTT to investigate their 
association as biomarkers of diabetes. Alt-
hough traditional risk factors like fasting glu-
cose, BMI and dietary patterns inform us 
about the future diabetes risk, however, it will 
be important to know the mechanisms by 
which 1-deoxySLs might promote the diabe-
tes. The correlation of 1-dexoySLs with glu-
cose levels of OGTT revealed that these are 
the reliable biomarkers of OGTT. 1-deox-
ySLs are not only elevated early in the course 
of diabetes development but might also be in-
volved in the pathogenesis of T2DM. The el-
evated level of 1-deoxySLs may not only 
serve as diagnostic biomarker but might also 
improve risk prediction and enable the timely 
prevention of diabetes (Othman et al., 2012). 
However further studies might be required to 
understand the interaction between sphin-
golipids, and glucose metabolism. These 
metabolomics studies in connection with oral 
glucose metabolism in healthy subjects dur-
ing an OGTT have the potential to advance 
our knowledge of metabolism in normal con-
ditions. Moreover information about the se-
lected sphingolipids analyzed by such ap-
proaches might improve the investigation of 
metabolism in health and disease. The sup-
posed biomarkers i.e., 1-deoxySLs and their 
ratios with respect to C18SAdiene might be 
used for the identification of subjects with 
risk of perturbed glycemic and metabolic con-
trol and also for those subjects who require 
future prevention and treatment. However 
further investigations are required to link 
these metabolites with glucose level of differ-
ent time points during an OGTT in normal as 
well as in subjects with impaired glucose tol-
erance.  
 
CONCLUSION 
The OGTT in normal subjects was carried 
out for the evaluation of impaired glucose tol-
erance, and risk of future diabetes in these 
subjects. The total blood glucose response vs 
time was measured by tAUC, iAUC, and 
pAUC. The correlation studies of AUC and 
different glucose levels measured during 
OGTT concluded that tAUC showed best cor-
relation with the 2-hour glucose level of 
OGTT. The total glucose response can be bet-
ter represented by the tAUC rather than 
iAUC, pAUC and it can be applied for the as-
sessment of total glucose load and diabetes di-
agnosis. Furthermore in this study the sphin-
goid-base profile was explored and correlated 
with tAUC and 2-hour glucose level of 
OGTT. Our findings suggest that 1-deoxySLs 
and their ratios with C18SAdiene could be 
significantly correlated with 2-hour glucose 
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level and tAUC of OGTT. Moreover these ra-
tios are higher in subjects with IGT and were 
highly correlated with 2-hour blood glucose 
level of OGTT in comparison with normal 
subjects. The 1-deoxySLs and their ratios 
with C18SAdiene might be used as a bio-
marker for glucose metabolism and diabetes 
diagnosis in future and the accuracy of the 
OGTT for the prediction of diabetes would be 
much more improved by using these addi-
tional biomarkers. Our study is different from 
the previous studies. We explored not only the 
relationship between different time points 
blood glucose level of OGTT with total, in-
cremental, and positive incremental AUC, to 
find the best method for measuring total glu-
cose load but also correlated sphingoid-base 
profile to 2-hour glucose and tAUC of OGTT 
in order to find other novel predictors for the 
diagnosis of diabetes. Finding other reliable 
predictors along with 2-hour glucose values 
of OGTT is essential to enhance the predicta-
bility of diabetes and its diagnosis can be per-
formed more accurately in the future. This 
might also be critical for identifying persons 
at high risk, and then describing this group for 
intervention and other preventive measures. 
Although traditional risk factors like fasting 
glucose, BMI and dietary patterns inform us 
about the future diabetes risk however it will 
be important to know the mechanisms by 
which 1-deoxySLs might promote the diabe-
tes. 
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